Dr. Ben Bikman

And so there's no even suspicion that the glucose could not only be contributing to these problems, but that there is any problem, metabolically speaking. But while the glucose levels have stayed at a normal range during all these years, decades even, the hormone insulin has been the canary in the coal mine. It has been increasing steadily year over year over year.

And so there's no even suspicion that the glucose could not only be contributing to these problems, but that there is any problem, metabolically speaking. But while the glucose levels have stayed at a normal range during all these years, decades even, the hormone insulin has been the canary in the coal mine. It has been increasing steadily year over year over year.

And so to answer your question explicitly, if I were to say is there a marker that has been overlooked, it is fasting insulin completely, full stop. Because it is the earliest sign of metabolic disruption that if we could shift

And so to answer your question explicitly, if I were to say is there a marker that has been overlooked, it is fasting insulin completely, full stop. Because it is the earliest sign of metabolic disruption that if we could shift

And so to answer your question explicitly, if I were to say is there a marker that has been overlooked, it is fasting insulin completely, full stop. Because it is the earliest sign of metabolic disruption that if we could shift

from the glucose-centric paradigm away from the glucose and have an insulin-centric paradigm, by measuring insulin, we can not only detect the problems decades before they manifest, in other words, insulin would be elevated potentially 10 or 20 years before the glucose ever starts to change, so we detect it at its earliest stages,

from the glucose-centric paradigm away from the glucose and have an insulin-centric paradigm, by measuring insulin, we can not only detect the problems decades before they manifest, in other words, insulin would be elevated potentially 10 or 20 years before the glucose ever starts to change, so we detect it at its earliest stages,

from the glucose-centric paradigm away from the glucose and have an insulin-centric paradigm, by measuring insulin, we can not only detect the problems decades before they manifest, in other words, insulin would be elevated potentially 10 or 20 years before the glucose ever starts to change, so we detect it at its earliest stages,

But by focusing on the insulin, we also embrace more effective strategies. Because with a glucose-centric paradigm, conventional clinical care will say, we need to lower the glucose at all costs, even at the expense of increasing insulin.

But by focusing on the insulin, we also embrace more effective strategies. Because with a glucose-centric paradigm, conventional clinical care will say, we need to lower the glucose at all costs, even at the expense of increasing insulin.

But by focusing on the insulin, we also embrace more effective strategies. Because with a glucose-centric paradigm, conventional clinical care will say, we need to lower the glucose at all costs, even at the expense of increasing insulin.

and that is a way to make people fatter and sicker, which is why people with type 2 diabetes who are given insulin therapy to correct their glucose, because it's only seen as a glucose disease, do in fact get fatter and die faster.

and that is a way to make people fatter and sicker, which is why people with type 2 diabetes who are given insulin therapy to correct their glucose, because it's only seen as a glucose disease, do in fact get fatter and die faster.

and that is a way to make people fatter and sicker, which is why people with type 2 diabetes who are given insulin therapy to correct their glucose, because it's only seen as a glucose disease, do in fact get fatter and die faster.

They're twice as likely to die from cancer, three times as likely to die from heart disease, twice as likely to develop Alzheimer's disease, because those chronic diseases are not problems of hyperglycemia per se, they're problems of hyperinsulinemia. So focus on the insulin.

They're twice as likely to die from cancer, three times as likely to die from heart disease, twice as likely to develop Alzheimer's disease, because those chronic diseases are not problems of hyperglycemia per se, they're problems of hyperinsulinemia. So focus on the insulin.

They're twice as likely to die from cancer, three times as likely to die from heart disease, twice as likely to develop Alzheimer's disease, because those chronic diseases are not problems of hyperglycemia per se, they're problems of hyperinsulinemia. So focus on the insulin.

We can detect problems sooner and we can treat them better because it's the high insulin that's contributing, not the high glucose. The high glucose is a symptom.

We can detect problems sooner and we can treat them better because it's the high insulin that's contributing, not the high glucose. The high glucose is a symptom.

We can detect problems sooner and we can treat them better because it's the high insulin that's contributing, not the high glucose. The high glucose is a symptom.